# Application of Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer Surgery

> **NCT07354698** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Daping Hospital and the Research Institute of Surgery of the Third Military Medical University** · enrollment: 114 (estimated)

## Conditions studied

- Papillary Thyroid Cancer

## Interventions

- **DRUG:** mitoxantrone hydrochloride injection

## Key facts

- **NCT ID:** NCT07354698
- **Lead sponsor:** Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2028-02-01
- **Final completion:** 2028-02-01
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07354698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07354698, "Application of Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer Surgery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07354698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*